President Donald Trump signed an order last month that requires the federal government to buy “essential” drugs from U.S. suppliers. The decision comes as no surprise for the president, who has been advocating for domestic pharmaceutical drug production during the past few months.
The Covid-19 pandemic has forced companies all over the U.S. to find domestic suppliers due to interruptions in foreign supply chains. The pharmaceutical supply chain is a growing issue as the U.S. races to create a Covid-19 vaccine. During March and April, medical supply chain disruptions were common–especially for drugs with active ingredients coming from China.
“We cannot rely on China and other nations across the globe that could one day deny us products,” Trump said Thursday from the Whirlpool Corporation Manufacturing Plant in Clyde, Ohio. “As we’ve seen in this pandemic, the U.S. must produce essential equipment supplies and pharmaceuticals for ourselves.”
The order, called “Buy American”, will require the government to develop a list of essential medicines and buy them as well as medical supplies from U.S. companies instead of from foreign countries like China. The president’s goal is to make the U.S. the “premiere medical manufacture, pharmacy and drug store of the world.”
Prior to the order, Trump announced a $765 million deal with camera company Kodak to make the active pharmaceutical ingredients that we rely so heavily on China for. Along with that, he is also trying to lower drug costs so that they can compete with overseas prices.
Learn more why this is so important from our partner, Rosemary Gibson, author of the eye-opening book, China Rx. She warned Congress in 2019 of the problem.